The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NIVOPOSTOP (GORTEC 2018-01): A phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse.
 
Jean Bourhis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD
 
Anne Auperin
No Relationships to Disclose
 
Christian Borel
Honoraria - Bristol-Myers Squibb; Merck KGaA; MSD Oncology
Consulting or Advisory Role - Bristol-Myers Squibb; Merck KGaA; MSD Oncology
Travel, Accommodations, Expenses - Merck KGaA; MSD Oncology
 
Gautier Lefebvre
No Relationships to Disclose
 
Severine Racadot
No Relationships to Disclose
 
Lionnel Geoffrois
Honoraria - BMS; Eisai Europe; Ipsen; Merck serono; MSD; Pfizer
Consulting or Advisory Role - Ipsen; Merck Serono
Travel, Accommodations, Expenses - Ipsen; Merck Serono; MSD Oncology
 
Xu Shan Sun
Travel, Accommodations, Expenses - MSD
 
Esma Saada
Consulting or Advisory Role - Merck; MSD
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Merck; MSD; Novartis
 
Beatriz Cirauqui
Consulting or Advisory Role - BMS GmbH & Co. KG; Merck; MSD
Speakers' Bureau - Bristol Myers Squibb Foundation; Favre; Merck; MSD
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation; Merck; MSD
 
Tomasz Rutkowski
No Relationships to Disclose
 
Stephanie Henry
Consulting or Advisory Role - AstraZeneca; bioteqPartner; BMSi; Eisai; Gilead Sciences; GlaxoSmithKline; Merck; MSD Oncology; Novartis; Sanofi
Travel, Accommodations, Expenses - GlaxoSmithKline; MSD Oncology; Roche; Teva
 
Anouchka Modesto
Research Funding - AstraZeneca/UK
Travel, Accommodations, Expenses - Merck
 
Alison Johnson
Honoraria - Gilead Sciences; Seagen
Research Funding - Roche
Travel, Accommodations, Expenses - Gilead Sciences; Lilly; MSD; Pfizer
 
Benoit Calderon
No Relationships to Disclose
 
Yoann Pointreau
Consulting or Advisory Role - Bristol Myers Squibb Foundation
 
Elisabeth Perez Ruiz
No Relationships to Disclose
 
Joanna Kazmierska
No Relationships to Disclose
 
Amanda Psyrri
Honoraria - Astrazeneca; Bayer; BMS; Genesis Pharmaceuticals; GlaxoSmithKline; Merck Serono; merus; MSD Oncology; Pfizer; Roche; seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; GlaxoSmithKline; Merus NV; MSD Oncology; Pfizer; Seagen
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; AstraZeneca
 
Ricard Mesia
Consulting or Advisory Role - Boehringer Ingelheim; GlaxoSmithKline; Merck KGaA; MSD; PDS Biotechnology; Regeneron; Roche; Seagan
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Merck KGaA; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; MSD
 
Yungan Tao
Honoraria - Merck Serono; MSD Oncology; Seagen
Consulting or Advisory Role - Merck Serono; MSD Oncology
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology
 
GORTEC
No Relationships to Disclose